Ocata Therapeutics Inc fka OCAT

[rumper]

The iPSC deal is another Slam Dunk!

Stem Cells are raw material for ALL of OCATs
product lines.

Now they have both eHSCs and iPSCs to manufacture with.

Let's hope the deal boxes out other companies from
eye therapies.

OCAT knows what to do with stem cells. This is what
their entire IP is about.

This is like a construction company that now owns its own
lumber and concrete plant.

Slam Dunk, and the backboard is shattered!

Another step forward fo OCAT.

Everything since the reverse split until now has been absolutely positive!